Short and long term impacts of COVID-19 on the pharmaceutical sector

Short and long term impacts of COVID-19 on the pharmaceutical sector
复制标题

DOI:
10.1007/s40199-020-00358-5
复制
发表时间:
2020-07-03
影响因子:
3.6
通讯作者:
Nikfar, Shekoufeh
Nikfar, Shekoufeh
中科院分区:
医学3区
文献类型:
--
作者:
Ayati, Nayyereh;Saiyarsarai, Parisa;Nikfar, Shekoufeh

文献摘要

被引文献

相似文献

背景 2020 年 3 月 11 日,世界卫生组织将 2019 新型冠状病毒病(COVID-19)定性为全球大流行病。这场大流行病对医疗市场、制药行业产生了重大影响,并产生了相当大的影响;这些可能会出现在短期和长期的时间范围内,需要识别和适当的规划来减轻其社会经济负担。 目标 当前的短期沟通研究评估了 COVID-19 时代的药品市场危机;讨论大流行对制药行业的短期和长期影响。结果 COVID-19 大流行的短期影响包括需求变化、法规修订、研发流程变化以及向远程通信和远程医疗的转变。此外,行业增长放缓、审批延迟、药品生产供应链走向自给自足、健康市场产品消费趋势变化以及道德困境可以预见为 COVID-19 大流行对全球和地方层面制药行业的长期影响。 结论 COVID-19 大流行对包括制药行业在内的健康市场造成了相当大的危机;并识别这些影响,可能会指导政策制定者制定更多基于证据的规划,以克服随之而来的挑战。
Background The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time-horizon and need identification and appropriate planning to reduce their socio-economic burden.Objectives Current short communication study assessed pharmaceutical market crisis during the COVID-19 era; discussing short- and long-term impacts of the pandemic on the pharmaceutical sector.Results Short-term impacts of COVID-19 pandemic includes demand changes, regulation revisions, research and development process changes and the shift towards tele-communication and tele-medicine. In addition, industry growth slow-down, approval delays, moving towards self-sufficiency in pharm-production supply chain and trend changes in consumption of health-market products along with ethical dilemma could be anticipated as long-term impacts of COVID-19 pandemic on pharmaceutical sector in both global and local levels.Conclusion The pandemic of COVID-19 poses considerable crisis on the health markets, including the pharmaceutical sector; and identification of these effects, may guide policy-makers towards more evidence-informed planning to overcome accompanying challenges.